IMMUNOHISTOCHEMISTRY, CYTOKERATIN 20

The IHC – Cytokeratin 20 (CK20) test is an immunohistochemistry-based diagnostic assay used to detect Cytokeratin 20 protein expression in tissue samples. CK20 is an intermediate filament protein found in specific epithelial cells, particularly those lining the gastrointestinal tract, urinary bladder, and certain mucosal tissues.

This test is widely used in surgical pathology and oncology to identify and classify epithelial tumors, especially colorectal adenocarcinoma and urothelial carcinoma. CK20 staining helps pathologists determine tumor origin and differentiate between primary and metastatic cancers.

Benefits of the Test

• Helps diagnose colorectal adenocarcinoma
• Assists in identifying urothelial carcinoma
• Supports determination of tumor origin
• Improves classification of epithelial malignancies
• Helps guide oncology treatment planning

Why Doctors Recommend This Test

Doctors recommend the IHC CK20 test when there is suspicion of gastrointestinal or urothelial cancers, or when the primary origin of a metastatic tumor is unclear. It is commonly used in:

• Diagnosis of colorectal cancer
• Evaluation of bladder and urothelial carcinoma
• Investigation of metastatic adenocarcinoma
• Tumor origin identification studies
• Oncology biopsy interpretation

CK20 is frequently used alongside markers such as CK7, CDX2, CEA, SATB2, GATA3, and Villin to improve diagnostic accuracy and establish the tissue of origin.

Preparation Before Test

No special preparation is required for this test. Important considerations include:

• The test is performed on a biopsy or surgical tissue sample
• No fasting or medication restrictions are needed
• Clinical history, imaging studies, and pathology findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on specimen processing and laboratory workflow.

Who Should Take This Test

• Patients with suspected colorectal cancer
• Individuals with suspected urothelial carcinoma
• Cases of metastatic tumors with unknown primary origin
• Patients undergoing gastrointestinal tumor evaluation
• Oncology patients requiring immunohistochemistry profiling

The IHC CK20 test is an important diagnostic tool in gastrointestinal and urological pathology. By identifying Cytokeratin 20 expression, it helps clinicians accurately classify epithelial tumors and determine the origin of metastatic cancers.

Clinical Significance

CK20 staining is particularly useful in the diagnosis and evaluation of:

• Colorectal adenocarcinoma
• Urothelial carcinoma
• Gastrointestinal tract tumors
• Mucinous adenocarcinomas
• Metastatic epithelial malignancies
• Tumors with uncertain primary origin